KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Sarepta Therapeutics (SRPT) over the last 13 years, with Q2 2025 value amounting to 0.11%.

  • Sarepta Therapeutics' Return on Capital Employed rose 1000.0% to 0.11% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.11%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.08% for FY2024, which is 1800.0% up from last year.
  • Sarepta Therapeutics' Return on Capital Employed amounted to 0.11% in Q2 2025, which was up 1000.0% from 0.07% recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Return on Capital Employed registered a high of 0.11% during Q2 2025, and its lowest value of 0.27% during Q2 2021.
  • Over the past 5 years, Sarepta Therapeutics' median Return on Capital Employed value was 0.18% (recorded in 2022), while the average stood at 0.13%.
  • As far as peak fluctuations go, Sarepta Therapeutics' Return on Capital Employed tumbled by -800bps in 2023, and later skyrocketed by 2100bps in 2024.
  • Sarepta Therapeutics' Return on Capital Employed (Quarter) stood at 0.19% in 2021, then fell by -13bps to 0.21% in 2022, then soared by 50bps to 0.11% in 2023, then skyrocketed by 168bps to 0.07% in 2024, then surged by 58bps to 0.11% in 2025.
  • Its last three reported values are 0.11% in Q2 2025, 0.07% for Q4 2024, and 0.03% during Q3 2024.